CECecilia Ezcurra

Cecilia Ezcurra

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Cecilia Ezcurra has a total of 120 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Clinical Characteristics and Outcomes of Bloodstream Infections Caused by Metallo-β-Lactamase–Producing Enterobacterales in Argentina: A Subanalysis of the EMBARCAR Prospective Multicenter Cohort Study

    by Ezequiel Cordova, Juan Pablo Balbuena, Analia Mykietiuk, Javier Farina, Marcelo Gañete, Pablo Scapellato, María Inés Lespada, Esteban Nannini, Rosa Contreras, Eleonora Cunto, et al.

    Background: Bloodstream infections (BSI) caused by metallo-beta-lactamase (MBL)-producing Enterobacterales (E) are associated with high mortality. However, in most Latin American countries there is a lack of clinical and microbiological data on BSI caused by MBL-E. Methods: This preplanned subgroup analysis of the multicenter, observational, prospective EMBARCAR study focused on adult patients with BSI caused by MBL-E in Argentina. Logistic regression adjusted by propensity scores (PS) for the treatment with ceftazidime-avibactam plus aztreonam (CAZ/AVI plus ATM) were used to identify variables associated with mortality. Results: A total of 140 patients with BSI caused by MBL-producing Enterobacterales were included. Median age was 59 years (IQR 46–70), and most patients were male (61%). Most frequent comorbidities were diabetes 23%, class III obesity 19%, and chronic renal failure 19%. Two thirds of patients were hospitalized in critical care units, 60% required mechanical ventilation and 38% presented with shock. Most frequent isolated microorganisms were Klebsiella pneumoniae (75%) and Serratia marcescens (12%). Most patients (64%) received combination therapy and 23% received CAZ/AVI plus ATM. Thirty-day mortality was 41%. In the multivariate PS adjusted analysis, INCREMENT-CPE score ≥8 was associated with increased risk of mortality (odds ratio [OR] 3.63; 95% CI: 1.13, 11.7), while CAZ/AVI plus ATM therapy with a lower risk of death (OR 0.18; 95% CI: .05, .58). Conclusions: In summary, BSI due to MBL-producing Enterobacterales resulted in a high mortality rate in our country. The use of CAZ/AVI plus ATM was associated with a decreased mortality. Better access to these antibiotics should be granted.


  • Open Access

    Multicenter Evaluation of Antibiotic Use and Antibiotic Stewardship Programs in Latin American Hospitals

    by Valeria Fabre, Sara E Cosgrove, Yea-Jen Hsu, Twisha S Patel, Fernanda C Lessa, Andrea Alvarado, Bowen Aquiles, Ana B Arauz, Maria F Barberis, Maria Del Carmen Bangher, et al.

    Background: There is limited knowledge on the extent of antimicrobial stewardship program (ASP) implementation in health care facilities (HCFs) in Latin America. Methods: We performed an evaluation of ASPs in Latin American HCFs from March 2022 to February 2023 using a structured self-assessment survey associated with a scoring system that evaluated leadership support and accountability, resources, antibiotic stewardship actions, education, and antibiotic use (AU) monitoring and reporting. Additionally, we collected monthly AU data (antibiotic consumption and point prevalence surveys) and number of multidrug-resistant infections in medical-surgical intensive care units. Self-assessment scores were correlated with AU through multivariable regression models adjusting for bed size, country of HCF, and incidence of infections (when appropriate). Results: Of the 39 HCFs recruited for the study, all completed the self-assessment, 36 performed the point prevalence survey, and 29 collected antibiotic consumption data. The overall median self-assessment score was 252.5 (IQR, 212.5–285) for a maximum possible score of 335. A high self-assessment score (top quartile) was associated with higher guideline-compliant AU (odds ratio [OR], 8.63; 95% CI, 3.03–24.6; P < .001), higher use of directed therapy (OR, 2.11; 95% CI, 1.41–3.1; P < .001), and less consumption of anti–methicillin-resistant Staphylococcus aureus agents (OR, −8.59; SE = 4.12; P = .037) after adjusting for bed size, country, and incidence of methicillin-resistant S aureus infections. Conclusions: Higher-level ASP implementation in Latin American HCFs correlated with better compliance with AU guidelines and decreased the use of vancomycin in the intensive care unit, supporting the need to improve resources for ASPs.


  • Open Access

    Guía intersociedades de profilaxis antibiótica quirúrgica en pacientes adultos

    by Liliana Clara, Ana Laura Chattas, Javier Eduardo Desse, Edith A. Carbone, Rosana L. Cuini, Cecilia Ezcurra, Claudia G. Rodríguez, Cecilia Vera Ocampo, Sofía Sabato, Ana Mercedes Kunst, et al.

    Se estima que aproximadamente uno a tres de cada mil pacientes sometidos a cirugía sufrirá una infección vinculada con el procedimiento (1). Incluso, probablemente esa cifra sea aun mayor en los en los países en desarrollo. De más está decir que esto se asocia con un elevado impacto en vidas humanas y en gastos relacionados. Numerosas publicaciones indican que la adecuada instrumentación de un conjunto de medi- das preventivas es una herramienta útil para intentar evitar o disminuir el desarrollo de infec- ciones asociadas al acto quirúrgico (2). La correcta profilaxis antibiótica prequirúrgica es uno de los pilares para la prevención de infecciones del sitio quirúrgico (ISQ). Su finalidad es impedir la aparición de ISQ a través de lograr alcanzar los niveles de concentración óptima de los antibióticos en sangre y tejidos, para evitar la proliferación y diseminación bacteriana. Para ello es preciso contar con datos actualizados de la microbiología local a fin de adecuar los tratamientos a la situación epidemiológica y con protocolos que permitan una adecuada administración de los antibióticos en tiempo y forma, así como un correcto seguimiento de todo el proceso. Con ese objetivo, la Sociedad Argentina de Infectología convocó a la Asociación Argentina de Cirugía y a la Asociación de Anestesia, Analgesia y Reanimación de Buenos Aires para tra- bajar de manera consensuada en la actualización de las recomendaciones emitidas en 2017 (3), con una visión que permita un enfoque multidisciplinario. Creemos que este documento será de gran utilidad para todos los agentes involucrados en el manejo de pacientes quirúrgicos, así como una herramienta fundamental para el control de las infecciones asociadas al cuidado de la salud.